Fakhrossadat Emami

1.0k citations
20 papers · 794 indexed · h-index 14
Topics
Nanoplatforms for cancer theranostics (10 papers)Nanoparticle-Based Drug Delivery (6 papers)Inhalation and Respiratory Drug Delivery (5 papers)

In The Last Decade

Fakhrossadat Emami

20 papers receiving 787 citations

Peers

Fakhrossadat Emami
Comparison fields: 5 of 95
  • Biomedical Engineering 292
  • Molecular Biology 278
  • Biomaterials 262
  • Pulmonary and Respiratory Medicine 171
  • Pharmaceutical Science 130
Replace Hassan A. Albarqi with:
Hassan A. Albarqi Saudi Arabia
P. Grenier Canada
Brandon Smith United States
Silvia Ferrati United States
Federica Foglietta Italy
Carolin Weber Germany
Ava M. Vargason United States
Ana Loureiro Portugal
Youssef W. Naguib United States
Ju Du China
Fakhrossadat Emami relative to Hassan A. Albarqi Saudi Arabia Hassan A. Albarqi's profile →
Citations per field
00.5×1.5×2.2×
Hassan A. Albarqi · 1×
Citations per year

Countries citing papers authored by Fakhrossadat Emami

Since Specialization
Citations

This map shows the geographic impact of Fakhrossadat Emami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fakhrossadat Emami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fakhrossadat Emami more than expected).

Fields of papers citing papers by Fakhrossadat Emami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fakhrossadat Emami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fakhrossadat Emami. The network helps show where Fakhrossadat Emami may publish in the future.

Co-authorship network of co-authors of Fakhrossadat Emami

This figure shows the co-authorship network connecting the top 25 collaborators of Fakhrossadat Emami. A scholar is included among the top collaborators of Fakhrossadat Emami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fakhrossadat Emami. Fakhrossadat Emami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 1
3 34
4 7
5 25
6 26
7 8
8 46
9 10
10 47
11 137
12 38
13 3
14 95
15 19
16 30
17 32
18 198
19
Evaluation of Residual Diazinon and Chlorpiryfos in Children Herbal Medicines by Headspace-SPME and GC-FID.
8
20 14

About Fakhrossadat Emami

Fakhrossadat Emami is a scholar working on Biomaterials, Food Science and Biomedical Engineering, having authored 20 papers that have together received 794 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). The work is most often cited by research in Pharmaceutical Science (130 citations), Biomaterials (262 citations) and Biomedical Engineering (292 citations). Fakhrossadat Emami has collaborated with scholars based in South Korea, Iran and United States. Frequent co-authors include Dong Hee Na, Alireza Vatanara, Simmyung Yook, Jee‐Heon Jeong, Eun Ji Park, Seyed Jamaleddin Mostafavi Yazdi, Asmita Banstola, Jong Oh Kim, Soo‐Yeon Lee and Ramesh Duwa. Their work appears in journals such as Journal of Controlled Release, Biomedicine & Pharmacotherapy and Molecular Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026